You searched for "diabetes"
Sense Medical and Canon: Getting ready for the OCT Pathway in Diabetic Eye Screening Surveillance Pathway webinar
4 September 2024
Are you ready for the OCT pathway in DESP?
OCT is set to be integrated into the English National Diabetic Eye Screening Surveillance Pathway, significantly enhancing the management of patients with mild diabetic maculopathy. This advancement allows patients to remain within a surveillance pathway overseen by retinal screening rather than being immediately referred to the Hospital Eye Service (HES).
The webinar will be hosted by Professor Tunde Peto and Mrs Samantha Mann and will discuss the new OCT pathway, how OCT will change diabetic screening, how to interpret OCT images and how programmes can get ready for the change.
Starts at 6pm UK time for 90 minutes
Does intravitreal bevacizumab help in diabetic retinopathy related vitreous haemorrhage?
1 October 2017
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
This retrospective, interventional case series, aimed to assess the effectiveness of intravitreal bevacizumab (IVB) in vitreous haemorrhage secondary to proliferative diabetic retinopathy. The primary outcome was the rate of vitrectomy (PPV) after IVB, with secondary outcomes the number of IVB...
Management of diabetic macular oedema in vitrectomised eyes
1 August 2016
| Maged Habib
|
EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is one of the leading causes of blindness; its prevalence is on the rise with progressive increase in numbers of people suffering from diabetes. The management of DMO has evolved significantly over the past few years....
Good news: new study links moderate wine consumption to lower risk of cataract surgery
31 March 2021
An observational study published today in Ophthalmology (the journal of the American Academy of Ophthalmology) indicates that low to moderate alcohol consumption is associated with a lower risk of requiring surgery for cataracts, although the nature of the study means it does not definitively prove a direct causal effect.
Children with ‘lazy eye’ are at increased risk of serious disease in adulthood
Adults who had amblyopia (‘lazy eye’) in childhood are more likely to experience hypertension, obesity, and metabolic syndrome in adulthood, as well as an increased risk of heart attack, finds a new study led by UCL researchers.Part 3: The Arclight Project: Implementation workshops
2 August 2024
| Andrew Blaikie, Chimgee Chuluunkhuu, Henry E Marealle, Frank Maliko, Dechen Wangmo
|
EYE - General
In this three-part series (Click here for Part 1 and Part 2) Andrew Blaikie and his team explore the role and application of the Arclight Device in Imaging of the Eye. The Arclight Project aims to support and enhance the...
Moorfields medical retina consent pathways course
28 February 2025
This brand new, unique MR Pathways consent course is specially designed for nurses, optometrists, doctors and others healthcare professional groups working in medical retina subspeciality in ophthalmology. The MR Pathway consent course enables the multi professional groups to embed the...
Outcomes of treat & extend ranibizumab in diabetic macular oedema
1 October 2021
| Ed Rule
|
EYE - Vitreo-Retinal
|
Diabetic macular edema, Outcome predictor, Ranibizumab, Spectral-domain optical coherence tomography, Treat and extend
This study retrospectively evaluated 118 eyes of 87 patients who received ranibizumab in a treat and extend regimen for diabetic macular oedema (DMO). Data were collected for patients under follow-up for 24 months. After 24 months, patients gained a mean...
Two-year interim safety results of the 0.2ug/day FAC intravitreal implant for the treatment of DMO
1 December 2021
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a 24-month interim prospective observational study of 95 previously steroid challenged patients (115 eyes) receiving intravitreal 0.2ug/day fluocinolone acetaid (FAC) implant for diabetic macular oedema (DMO) treatment. The mean IOP for pre- and post- FAC implants were stable,...
Posterior capsular rupture risk factors as reported in the European registry
In this cross-sectional review of the European Registry of Quality Outcomes for Cataract and Refractive Surgery (EUREQUO) including 2,853,376 patients and 31,749 cases with posterior capsular rupture (PCR), the authors observed a trend of reduction in PCR rate from 1.44%...Bromfenac versus betamethasone in diabetic macular oedema
31 October 2023
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Diabetic macular edema, betamethasone, bromfenac, central subfield thickness, intraocular pressure
This is a randomised, prospective, single-centre trial in patients diagnosed with diabetic macular oedema (DMO) with central subfield thickness (CST) of 250-500µm, who refused anti-VEGF treatment. Nineteen eyes of 19 patients were randomised to bromfenac (BF) or betamethasone (BM) drops,...
The compendium to clinical evidence in DMO treatment
3 April 2024
| Zhihang Cheng
|
EYE - Vitreo-Retinal
This review article summarises the current evidence base in the treatment options for diabetic macular oedema (DMO). The authors have included many real-world data studies that provided valuable insights into the optimal management of DMO. The authors argue that these...